Merck tightens manufacturing supply chain; Cheap HPV vaccines may appear without patent infringement;

> Merck is realigning its global manufacturing network to create a focused, more fully-utilized and cost-efficient worldwide supply chain. Release

> Study says vaccine makers from developing countries may be able to produce an HPV vaccine at low cost without infringing patents. Article

> Contract manufacturer AAIPharma and nanotech supplier CritiTech have allied to offer biopharma companies an alternative to conventional parenteral administration that aims to improve the delivery of molecules having low aqueous solubility or poor bioavailability. Article

> OctoPlus will perform process development and clinical manufacturing for The Medicines Co's MDCO-216 drug candidate. Announcement

> Amneal Pharmaceuticals has named Shankar Hariharan chief scientific officer/exec VP for specialty pharmaceuticals. Release

Suggested Articles

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.